Sernova Corporation

Sernova is a clinical-stage company developing products for the treatment of chronic debilitating diseases using therapeutic cells transplanted into an implanted medical device, the Cell Pouch™. The Cell Pouch™ forms a natural environment for the long-term survival and function of the therapeutic cells which release needed proteins or hormones. The company’s first products are for the treatment of insulin-dependent diabetes. Sernova’s Cell Pouch™, combined with its Sertolin™ local immune protection technology, offers therapeutic cells local protection from immune system attack creating an effective, safe, long-term and convenient therapeutic option for patients with chronic disease who seek to improve their quality of life.